# Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis

> **NCT00847886** · PHASE1 · COMPLETED · sponsor: **Lexicon Pharmaceuticals** · enrollment: 15 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** LX3305
- **DRUG:** LX3305 Placebo
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT00847886
- **Lead sponsor:** Lexicon Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2010-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00847886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00847886, "Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00847886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*